Nattopharma ASA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nattopharma ASA with three other
pharmaceutical manufacturers in Europe:
sales of 3.48 million Euro [US$3.79 million]
of which 88%
was Orphan Products Oncology),
(3.27 million Euro [US$3.55 million]
of which 70%
was Drug Discovery & Development), and
Santhera Pharmaceuticals Holding AG
based in Switzerland
(4.32 million Swiss Francs [US$4.36 million]
of which 100%
was Pharmaceutical Products).
During the year ended December of 2015, sales at
Nattopharma ASA were NOK 31.69 million (US$3.84 million).
increase of 24.8%
versus 2014, when the company's sales were NOK 25.39 million.
This was the fourth straight year of sales growth at Nattopharma ASA.